ATE230412T1 - Östrogene 19-norandrost-17-on-derivate mit einem aromatischen b-ring - Google Patents

Östrogene 19-norandrost-17-on-derivate mit einem aromatischen b-ring

Info

Publication number
ATE230412T1
ATE230412T1 AT98918788T AT98918788T ATE230412T1 AT E230412 T1 ATE230412 T1 AT E230412T1 AT 98918788 T AT98918788 T AT 98918788T AT 98918788 T AT98918788 T AT 98918788T AT E230412 T1 ATE230412 T1 AT E230412T1
Authority
AT
Austria
Prior art keywords
norandrost
estrogenic
aromatic
derivatives
ring
Prior art date
Application number
AT98918788T
Other languages
English (en)
Inventor
Syed Muzafar Shah
Panolil Raveendranath
Michael Z Kagan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE230412T1 publication Critical patent/ATE230412T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005Glycosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98918788T 1997-05-02 1998-04-28 Östrogene 19-norandrost-17-on-derivate mit einem aromatischen b-ring ATE230412T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85042797A 1997-05-02 1997-05-02
PCT/US1998/008455 WO1998050412A1 (en) 1997-05-02 1998-04-28 Estrogenic 19-noradnrost-17-one derivatives with an aromatic b-ring

Publications (1)

Publication Number Publication Date
ATE230412T1 true ATE230412T1 (de) 2003-01-15

Family

ID=25308082

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98918788T ATE230412T1 (de) 1997-05-02 1998-04-28 Östrogene 19-norandrost-17-on-derivate mit einem aromatischen b-ring

Country Status (15)

Country Link
EP (1) EP0980382B1 (de)
JP (1) JP2001525806A (de)
KR (1) KR20010012155A (de)
CN (1) CN1254344A (de)
AR (1) AR012639A1 (de)
AT (1) ATE230412T1 (de)
AU (1) AU755007B2 (de)
BR (1) BR9809436A (de)
CA (1) CA2288999A1 (de)
DE (1) DE69810460T2 (de)
DK (1) DK0980382T3 (de)
ES (1) ES2187962T3 (de)
PT (1) PT980382E (de)
WO (1) WO1998050412A1 (de)
ZA (1) ZA983688B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104557489B (zh) * 2014-11-22 2016-06-29 太原理工大学 一种3-环戊基丙醛的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB864231A (en) * 1958-08-07 1961-03-29 Glaxo Lab Ltd Improvements in or relating to the preparation of steroids

Also Published As

Publication number Publication date
EP0980382A1 (de) 2000-02-23
ZA983688B (en) 1999-11-01
AU755007B2 (en) 2002-11-28
DE69810460D1 (de) 2003-02-06
DE69810460T2 (de) 2003-10-02
KR20010012155A (ko) 2001-02-15
JP2001525806A (ja) 2001-12-11
PT980382E (pt) 2003-03-31
AU7164698A (en) 1998-11-27
WO1998050412A1 (en) 1998-11-12
CA2288999A1 (en) 1998-11-12
EP0980382B1 (de) 2003-01-02
DK0980382T3 (da) 2003-04-14
BR9809436A (pt) 2000-06-13
AR012639A1 (es) 2000-11-08
CN1254344A (zh) 2000-05-24
HK1025776A1 (en) 2000-11-24
ES2187962T3 (es) 2003-06-16

Similar Documents

Publication Publication Date Title
NL300416I2 (nl) Estrogene middelen
BR9701879A (pt) Agentes estrogênicos
DE69735712D1 (de) Aryl-pyrimidin-derivate
DK0891332T3 (da) 6-phenylpyridyl-2-aminderivater
IS4800A (is) Nýjar 19-nor-pregnene afleiður
DE69826286D1 (de) Derivate mit einem aromatischen ring
NO20001788D0 (no) Kjernebor
DE59709549D1 (de) Vormischbrenner
NO981946D0 (no) Imidazoquinazolin-derivater
EE200000140A (et) Asendatud kromaani derivaadid
DK1070059T3 (da) Chromanon- og thiochromanonderivater
NO20000057D0 (no) Kjerneroer
EE200000144A (et) Asendatud kromaani derivaadid
IS5026A (is) 2-metoxýfenýlpíperasín afleiður
ATE230412T1 (de) Östrogene 19-norandrost-17-on-derivate mit einem aromatischen b-ring
DK1102769T3 (da) Tricykliske carboxamider
NO993171D0 (no) Substituerte propionylderivater
FI965181A7 (fi) Polyalkoholi-peptidijohdannaiset
EE9900463A (et) Raadioliini kohastumine
DE69802830D1 (de) Aromatische substituierte naphtopyranen
ITBO960020A0 (it) Aeroporto sopraelevato
KR970064047U (ko) 변압기
FI961703A0 (fi) Galler
FI962460A0 (fi) Lyftbart galler foer loesdriftshoensgaord
DK103297A (da) Antioxidant

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0980382

Country of ref document: EP

REN Ceased due to non-payment of the annual fee